Top Markets
Coin of the day
Synairgen plc Synairgen plc

Synairgen plc

SNG
Classifica tra le azioni #40400
Synairgen plc specializes in the research and development of pharmaceutical... Synairgen plc specializes in the research and development of pharmaceutical treatments for various respiratory conditions. Its product pipeline includes SNG001, an inhaled interferon beta currently being developed for COVID-19. The company is also advancing an inhaled form of interferon beta (IFN-ß) through Phase II clinical trials for the management of asthma triggered by common colds and influenza, as well as for the treatment or prevention of chronic obstructive pulmonary disease. Furthermore, Synairgen is developing a LOXL2 inhibitor intended for treating idiopathic pulmonary fibrosis (IPF). To support the development of this LOXL2 inhibitor, the company maintains a licensing and collaboration agreement with Pharmaxis Ltd. Synairgen plc was established in 2004 and is headquartered in Southampton, United Kingdom.
Prezzo delle azioni
$0.01292666
Ultima sincronizzazione: 2025-04-08
Capitalizzazione di mercato
$157.54K
Variazione (1 giorno)
6.84%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Synairgen plc (SNG)

Categoria

EPS per Synairgen plc (SNG)
EPS al June 2024 TTM: $-0.04
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Synairgen plc, l’EPS attuale della società (TTM) è $-0.04. Alla fine del 2022, la società aveva un EPS di $-0.11 una diminuzione rispetto a rispetto a quello del 2021, che era di $-0.32.
Storico EPS per Synairgen plc da 2004 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $-0.04 -13.00%
2023 $-0.05 -49.81%
2022 $-0.11 -67.33%
2021 $-0.32 150.97%
2020 $-0.13 176.28%
2019 $-0.05 5.88%
2018 $-0.04 -274.70%
2017 $0.03 -166.75%
2016 $-0.04 4.12%
2015 $-0.04 -273.33%
2014 $0.02 -146.98%
2013 $-0.04 -11.13%
2012 $-0.05 -41.31%
2011 $-0.09 34.96%
2010 $-0.06 -65.03%
2009 $-0.18 -7.49%
2008 $-0.20 44.55%
2007 $-0.14 67.04%
2006 $-0.08 39.93%
2005 $-0.06 112.04%
2004 $-0.03 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
$17.32 -39,916.09%
US
$27.74 -63,870.11%
NL
- -
CH
- -
KR
$13.70 -31,594.48%
BE